| Literature DB >> 36080269 |
Dina M El-Kersh1, Rania F Abou El-Ezz2, Marwa Fouad3,4, Mohamed A Farag5.
Abstract
Acylated flavonoids are widely distributed natural metabolites in medicinal plants and foods with several health attributes. A large diversity of chemical structures of acylated flavonoids with interesting biological effects was reported from several plant species. Of these, 123 compounds with potential antimicrobial, antiparasitic, anti-inflammatory, anti-nociceptive, analgesic, and anti-complementary effects were selected from several databases including SCI-Finder, Scopus, Google Scholar, Science Direct, PubMed, and others. Some selected reported biologically active flavonoids were docked in the active binding sites of some natural enzymes, namely acetylcholinesterase, butyrylcholinesterase, α-amylase, α-glucosidase, aldose reductase, and HIV integrase, in an attempt to underline the key interactions that might be responsible for their biological activities.Entities:
Keywords: acetylcholinesterase; acylated flavonoids; anti-diabetic; hepatoprotective; medicinal plants
Mesh:
Substances:
Year: 2022 PMID: 36080269 PMCID: PMC9458193 DOI: 10.3390/molecules27175501
Source DB: PubMed Journal: Molecules ISSN: 1420-3049 Impact factor: 4.927
Figure 1Chemical modifications on flavonoid structure.
Figure 2Chemical structures (1–85) of acylated flavonoids.
Figure 3Acylated anthocyanins’ impact on hepatocytes in sweet purple potato.
Figure 4SAR of acylated flavonoid glycosides on Anti-cholinesterase with impact on AD.
Plants having neuroprotective action “Acetyl, butyrylcholinesterase natural inhibitors”.
| Acylated Flavonoids | Plant Source | Biological Action | Reference |
|---|---|---|---|
| Caffeoyl acylated glycosides |
| High inhibitory effect on butyrylcholinestearse enzyme. | [ |
| 7- |
| Inhibitory effect on butyrylcholinestearse enzymes | [ |
| Kaempferol 3- |
| -Strong inhibitory activity on acetylcholinesterase | [ |
| Quercetin-3- |
| Neuroprotective action and anti-AD | [ |
| Quercetin-3- |
| Increased dopamine and acetyl choline neurotransmitters alleviating cognitive properties | [ |
| Kaempferol-3- |
| Weak inhibitory activity against cholinesterase, butyryl esterase, and lipoxygenase enzymes | [ |
| Quercetin-3- | Neuroprotective action on rat cortical cells injured by glutamate | [ | |
| 6’’’-(–)-phaseoylspinosin (32) |
| Moderate inhibitory impact on acetylcholinesterase | [ |
| Isoscutellarein-7-(2’’-allosyl)-glucoside monoacetylated (35), Isoscutellarein-7-(2’’-allosyl)-glucoside diacetylated (36), Isoscutellarein-4’-methyl ether-7-(2’’-allosyl)-glucoside monoacetylated (37), Hypolaetin-7-(2’’-allosyl)-glucoside monoacetylated (38), Hypolaetin-4’-methyl ether-7-(2’’-allosyl)-glucoside monoacetylated (39), Hypolaetin-4’-methyl ether-7-(2’’-allosyl)-glucoside diacetylated (40), |
| Antioxidant, anticholinesterase activity, and neuroprotective | [ |
α-Amylase and α-glucosidase enzyme natural inhibitors.
| Acylated Flavonoids | Plant Source | Biological Action | Reference |
|---|---|---|---|
| 6’’- |
| Inhibitory effects on α-amylase, natural antidiabetic agent | [ |
| 6- | Red vinegar fermented with roots of purple-sweet potato enriched with peonidin-3-O-(2-O-(6-O-E-feruloyl-β-D-glucopyranosyl)-6-O-E-caffeoyl-β-D-glucopyranoside)-5-O-β-D-glucopyranoside) | Inhibitory effects on maltase and sucrase enzymes; no effect on α amylase; | [ |
| Linarin (45) |
| Treatment of stomach pain and dysmenorrhea | [ |
| kaempferol-3- | Potent α-glucosidase inhibition | [ | |
| Isoorientin 2’’-( | Antidiabetic through activation of insulin signaling | [ | |
| Panasenoside A (54) (quercetin-4’- | Chinese | Inhibitory activity against α-glucosidase | [ |
| Cyanidin (55) | Hypoglycemic activity by inhibition of α-glucosidase | [ | |
| C6’’-acetylated C3-glycosides of delphinidine (58), malvinidin (59) and petunidin (60) types | Three cultivars of blueberry | Inhibition of α-glucosidase | [ |
| Cyanidin-3- | Hypoglycemic activity through inhibition of α-glucosidase and improved insulin sensitivity in adipocytes resistant to insulin | [ |
Results of the validation of the docking protocol setup.
| PDB ID | Enzyme | Co-Crystallized Ligand | RMSD | Docking Score of the Co-Crystallized Ligand (kcal/mol) |
|---|---|---|---|---|
| 4EY7 | Acetylcholinesterase | Donepezil | 0.8427 | −12.7467 |
| 4BDS | Butyrylcholinesterase | Tacrine | 0.4496 | −9.3945 |
| 4W93 | α-amylase | montbretin A | 2.7060 | −32.5225 |
| 2QMJ | α-glucosidase | Acarbose | 0.5016 | −26.2699 |
| 3RX3 | aldose reductase | Sulindac | 1.0574 | −8.9588 |
| 1QS4 | HIV 1 integrase | 1-(5-chloroindol-3-yl)-3-hydroxy-3-(2H-tetrazol-5-yl)-propenone | 0.6840 | −10.2199 |
Figure 5(a): 3D superimposition of compounds 19, 24, 25, 32, and 33 bound to acetylcholinesterase; (b): 3D superimposition of compounds 20 and 21 bound to butyrylcholinesterase; (c): 3D Superimposition of compounds 41–43, 45, and 46 bound to α-amylase; (d): 3D superimposition of compounds 47, 48, and 54–57 bound to α-glucosidase; (e): 3D superimposition of compounds 64, 65, 70, and 71 bound to aldose reductase; (f): 3D docking pose of compound 78 bound to HIV-1 Integrase.